statistiche ricercatore

MARTIGNONI, EMILIA SILVANA

Distribuzione geografica

Continente	#
NA - Nord America	6.531
EU - Europa	3.620
AS - Asia	1.839
SA - Sud America	158
AF - Africa	80
OC - Oceania	7
Continente sconosciuto - Info sul continente non disponibili	6
Totale	12.241

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.472
IT - Italia	1.768
SG - Singapore	673
UA - Ucraina	618
SE - Svezia	288
VN - Vietnam	283
CN - Cina	267
TR - Turchia	245
HK - Hong Kong	217
FI - Finlandia	193
IE - Irlanda	193
GB - Regno Unito	171
BR - Brasile	135
DE - Germania	124
FR - Francia	100
RU - Federazione Russa	87
NG - Nigeria	68
IN - India	50
BD - Bangladesh	39
CA - Canada	39
BE - Belgio	21
JP - Giappone	17
MX - Messico	11
NL - Olanda	9
AT - Austria	8
ES - Italia	8
AR - Argentina	7
MY - Malesia	7
EU - Europa	6
IQ - Iraq	6
MD - Moldavia	6
ID - Indonesia	5
PL - Polonia	5
SA - Arabia Saudita	5
ZA - Sudafrica	5
BG - Bulgaria	4
NZ - Nuova Zelanda	4
PK - Pakistan	4
AU - Australia	3
CL - Cile	3
CO - Colombia	3
IL - Israele	3
LT - Lituania	3
PY - Paraguay	3
TH - Thailandia	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
BB - Barbados	2
DK - Danimarca	2
EC - Ecuador	2
HR - Croazia	2
HU - Ungheria	2
JM - Giamaica	2
JO - Giordania	2
KZ - Kazakistan	2
MA - Marocco	2
AZ - Azerbaigian	1
BO - Bolivia	1
BW - Botswana	1
CH - Svizzera	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
EG - Egitto	1
GL - Groenlandia	1
GR - Grecia	1
HN - Honduras	1
IM - Isola di Man	1
KG - Kirghizistan	1
KW - Kuwait	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MK - Macedonia	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
QA - Qatar	1
RO - Romania	1
SN - Senegal	1
SV - El Salvador	1
TN - Tunisia	1
TW - Taiwan	1
TZ - Tanzania	1
UZ - Uzbekistan	1
Totale	12.241

Salva come PNG Salva come JPEG

Città	#
Milan	1.302
Fairfield	796
Chandler	587
Jacksonville	463
Woodbridge	442
Ashburn	435
San Jose	379
Seattle	372
Singapore	355
Houston	328
Wilmington	302
Ann Arbor	253
Cambridge	250
Hong Kong	215
Dublin	192
Dallas	168
Chicago	161
Princeton	154
Izmir	145
Nyköping	144
Boardman	104
The Dalles	91
Dong Ket	88
San Mateo	77
Rome	74
Como	70
Abuja	68
Lauterbourg	68
Council Bluffs	67
Beijing	62
Dearborn	60
Hanoi	45
San Diego	44
Ho Chi Minh City	41
Ogden	33
Philadelphia	31
Los Angeles	29
Helsinki	27
New York	26
Santa Clara	23
Norwalk	20
Brussels	19
Düsseldorf	18
Pune	17
São Paulo	17
Munich	14
Tokyo	14
Edinburgh	13
London	12
Turku	12
Atlanta	11
Orem	11
Verona	11
Kunming	9
Nanjing	8
San Francisco	8
Hefei	7
Nanchang	7
Amsterdam	6
Auburn Hills	6
Brasília	6
Chennai	6
Guangzhou	6
Mexico City	6
Montreal	6
Stockholm	6
Toronto	6
Brooklyn	5
Catania	5
Dhaka	5
Frankfurt am Main	5
Kuala Lumpur	5
Miami	5
New Delhi	5
Chengdu	4
Chongqing	4
Fuzhou	4
Jinan	4
Johannesburg	4
Las Vegas	4
Milton Keynes	4
Nuremberg	4
Rio de Janeiro	4
Shanghai	4
Tianjin	4
Bari	3
Belo Horizonte	3
Bolzano	3
Boston	3
Charlotte	3
Columbus	3
Curitiba	3
Da Nang	3
Fayetteville	3
Fort Worth	3
Hangzhou	3
Hải Dương	3
Kocaeli	3
Madrid	3
Manchester	3
Totale	8.977

Salva come PNG Salva come JPEG

Nome	#
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias	247
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease	240
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms	219
Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.	201
Changes of neuroendocrine axes in patients with menstrual migraine.	193
Disordered pupil reactivity in Parkinson's disease.	186
CARDIOVASCULAR AUTONOMIC MODULATION AND ACTIVITY OF CAROTID BARORECEPTORS AT ALTITUDE.	186
Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents.	184
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women.	182
The brain as a target for adrenocortical steroids: cognitive implications.	181
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.	181
Free plasma catecholamine levels in healthy subjects: a basal and dynamic study.The influence of age.	181
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin.	180
Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants.	179
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.	178
The association of menstrual migraine with the premenstrual syndrome.	178
Combined response of plasma and platelet catecholamines to different types of short-term stress.	177
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease.	175
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.	173
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.	172
Neuroendocrine changes in luteal function in patients with premenstrual syndrome.	172
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment	172
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias.	171
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection.	170
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans.	168
Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study.	168
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.	168
Platelet catecholamines in cluster headache.	168
Is seborrhea a sign of autonomic impairment in Parkinson's disease?	167
An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.	166
Functional changes of the basal ganglia circuitry in Parkinson's disease.	165
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo.	165
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.	165
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo.	164
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease.	163
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.	163
The role of language areas in motor control dysfunction in Parkinson's disease.	162
Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients.	162
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease.	161
Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000 May-Jun;62(3):386-93.	161
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection.	160
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study.	159
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.	158
Non-hormonal therapy of premenstrual syndrome.	158
Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus.	158
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study.	156
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease	153
Parkinson's disease and reproductive life events.	152
Medical healthcare use in Parkinson’s disease: survey in a cohort of ambulatory patients in Italy.	152
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients	152
LISURIDE PLUS SELEGILINE IN THE TREATMENT OF EARLY PARKINSON'S DISEASE.	151
Motor complications of Parkinson's disease.	149
The influence of gender in the evaluation of platelet and plasma catecholamines.	148
Electrophysiological study on jaw-opening reflex recorded from digastric muscle in Parkinson's disease and primary cranial dystonias.	148
Hashimoto's thyroiditis in association with Tolosa Hunt syndrome: a case report.	147
Premenstrual dysphoric disorder and eating disorders.	147
Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000 Sep;62(1):63-88.	145
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter,crossover, controlled study.	145
Expression polymorphism of the blood-brain barrier component P-glycoprotein(MDR1) in relation to Parkinson's disease.	144
Active music therapy and Parkinson's disease: methods.	142
CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN PATIENTS: RELEVANCE OF POSTPRANDIAL HYPOTENSION.	138
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.	138
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.	137
The autonomic nervous system and hypoxia: mountain medicine.	135
ALTITUDE, EXERCISE, AND MOUNTAIN MEDICINE: LESSONS FROM THE FIELD.	133
Autonomic disorders in Parkinson's disease.	131
LISURIDE AND BROMOCRYPTINE IN L-DOPA STABLE-RESPONDER PARKINSONIAN PATIENTS: A COMPARATIVE, DOUBLE-BLIND EVALUATION OF CARDIOPRESSOR AND NEUROCHEMICAL EFFECTS.	131
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease	129
Terguride in stable Parkinson's disease.	124
The effects of physical exercise at high altitude on adrenocortical function in humans.	124
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.	121
Reproductive life milestones in women with Parkinson's disease.	119
Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study.	115
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial.	115
Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study.	114
COMT inhibition and safety.	111
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid.	103
Totale	12.256

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	42.037
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	42.037

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	166	0	0	0	0	0	0	0	0	0	0	0	166
2021/2022	824	93	66	80	112	12	46	28	38	30	116	62	141
2022/2023	1.405	104	89	219	128	93	302	0	172	165	46	59	28
2023/2024	1.987	342	358	334	355	361	88	6	69	47	14	2	11
2024/2025	1.019	2	31	245	31	13	67	11	68	130	61	79	281
2025/2026	2.205	123	100	111	218	287	100	579	71	272	124	103	117
Totale													12.256